Navigation Links
Damage to arteries from injury can be avoided with carbon monoxide

Heart ailments that are treated with angioplasty or a transplantation may result in injury of the arteries. While in transplantation there is an ever-present risk of rejection of the// organ, in angioplasty, placing a balloon in the artery causes damage to the vessel walls. This in turn triggers the immune system response. A new study has however, revealed that pre-treatment with carbon monoxide may protect the arteries from damage that occurs during such procedures.

Researchers at the University of Pittsburgh pre-treated lab rats with the gas carbon monoxide - normally considered a deadly poison. They discovered that the carbon monoxide spared much of the vessel damage associated with transplantation and angioplasty in the pre-treated rats. The researchers claim that the carbon monoxide blocks white cells of the immune system from infiltrating the damaged area, which stops the build up of plaque inside the vessels and so makes the procedures more successful in the long term. It was also observed that there was no negative effect from carbon monoxide exposure.

The study is being furthered in pigs, that are often considered as a very useful model of human heart disease.


'"/>




Page: 1

Related medicine news :

1. Evidence Links Protein Damage to Neurodegenerative diseases like Parkinsons and Alzheimers
2. Paracetamol May Cause Live Damage Warns Consumer Education and Research Centre
3. Arthritis Drug May Cause Liver Damage
4. Epilepsy Drug Helps Diabetic Nerve Damage
5. Different Sun Rays, Different Damage
6. Drug That Is Found To Reduce Heart Damage from Chemo
7. Cooling Can Reduce The Risk Of Brain Damage In Oxygen Deprived Newborns
8. Damaged Heart Rejuvenated By Stem Cells
9. Traffic Smoke May Damage DNA
10. Detecting DNA Damage With In-Vivo Alkaline Comet Assay
11. Its Possible To Grow Bone To Replace The Damaged Bone
Post Your Comments:
Breaking Medicine Technology:Boston Scientific Announces Pricing of $2 Billion of Senior Notes 2Boston Scientific Announces Pricing of $2 Billion of Senior Notes 3Genomic Health Announces Publication of Study of Oncotype DX(R) in Node-Positive Breast Cancer That Identifies Patients Who Do Not Appear to Benefit From Chemotherapy 2Genomic Health Announces Publication of Study of Oncotype DX(R) in Node-Positive Breast Cancer That Identifies Patients Who Do Not Appear to Benefit From Chemotherapy 3Genomic Health Announces Publication of Study of Oncotype DX(R) in Node-Positive Breast Cancer That Identifies Patients Who Do Not Appear to Benefit From Chemotherapy 4Genomic Health Announces Publication of Study of Oncotype DX(R) in Node-Positive Breast Cancer That Identifies Patients Who Do Not Appear to Benefit From Chemotherapy 5Phase III CONFIRM Study Shows FASLODEX(R) (fulvestrant) Injection 500 mg May Delay Time of Disease Progression Over 250-mg Dose in Postmenopausal Women With Hormone Receptor-Positive Advanced Breast Cancer 2Phase III CONFIRM Study Shows FASLODEX(R) (fulvestrant) Injection 500 mg May Delay Time of Disease Progression Over 250-mg Dose in Postmenopausal Women With Hormone Receptor-Positive Advanced Breast Cancer 3Phase III CONFIRM Study Shows FASLODEX(R) (fulvestrant) Injection 500 mg May Delay Time of Disease Progression Over 250-mg Dose in Postmenopausal Women With Hormone Receptor-Positive Advanced Breast Cancer 4Phase III CONFIRM Study Shows FASLODEX(R) (fulvestrant) Injection 500 mg May Delay Time of Disease Progression Over 250-mg Dose in Postmenopausal Women With Hormone Receptor-Positive Advanced Breast Cancer 5Phase III CONFIRM Study Shows FASLODEX(R) (fulvestrant) Injection 500 mg May Delay Time of Disease Progression Over 250-mg Dose in Postmenopausal Women With Hormone Receptor-Positive Advanced Breast Cancer 6GeoVax Labs Requests pre IND Meeting With FDA 14181 1GeoVax Labs Requests pre IND Meeting With FDA 14181 2GeoVax Labs Requests pre IND Meeting With FDA 14181 3Dalton Pharma Services Adds Formulation Development Services 57793 1Dalton Pharma Services Adds Formulation Development Services 57793 2Atlantic Partners with Childrens Hospital of Philadelphia to Create an Interactive 26 Educational Waiting Room 57788 1Atlantic Partners with Childrens Hospital of Philadelphia to Create an Interactive 26 Educational Waiting Room 57788 2